
The episode discusses the ongoing challenges of rising drug prices despite legislative efforts and explores the tactics used by manufacturers to maintain high costs.
Despite the passage of the Inflation Reduction Act, drug prices continue to rise. How are manufacturers using the patent, drug approval process, and courts to keep drug prices high, and what are the legislative solutions to these practices? The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.
Explore listener stats, chart rankings, contacts and more on the ASHPOfficial podcast page.